Axis 2
Studiedness
- Evidence amount
- 1.00
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 25
- Records after title/year deduplication
- 25
entity · release 2026-09-20
Limosilactobacillus reuteri RC-14
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Forms
- Capsule: 10 · counted across the 10 of 10 published products whose label states a form
- Brands carrying it
- 1md-nutrition (1) · jarrow-formulas (1) · renew-life (4) · thorne (1) · trubiotics (1) · the five largest of 7 brands with a published product
- Published product pages
- 10
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| TruBiotics Women's | not printed | not printed | not observed | Capsule | 84.03 |
| Renew Life Women's Wellness Vaginal & Urinary Complete | not printed | not printed | not observed | Capsule | 84.03 |
| NHC Natural Healthy Concepts Probiotic For Women | not printed | not printed | not observed | Capsule | 84.03 |
| Metagenics UltraFlora Women's | not printed | not printed | not observed | Capsule | 84.03 |
| Jarrow Formulas Fem Dophilus 1 Billion CFU | not printed | not printed | not observed | Capsule | 77.28 |
| 1MD Nutrition BiomeMD for Women | not printed | not printed | not observed | Capsule | 73.70 |
| Renew Life Ultimate Flora RTS Women's Probiotic 15 Billion | not printed | not printed | not observed | Capsule | 70.28 |
| Renew Life Ultimate Flora Probiotic Women's Vaginal 50 Billion | not printed | not printed | not observed | Capsule | 70.28 |
| Renew Life Ultimate Flora Women's Complete Probiotic 90 Billion | not printed | not printed | not observed | Capsule | 65.69 |
| Thorne Women's Daily Probiotic | not printed | not printed | not observed | Capsule | 41.21 |
Reformulations
Label changes involving this organism
12 change(s) to this organism's own row, observed on 3 product(s). A change is counted only between two snapshots whose ingredient rows were both parsed; a first observation is not a change.
- Renew Life Ultimate Flora Women's Complete Probiotic 90 Billion: 178996 → 250927, organism added to the label
- Renew Life Ultimate Flora Women's Complete Probiotic 90 Billion: 243261 → 250927, organism added to the label, potency basis unstated → through_expiry
- Renew Life Ultimate Flora Women's Complete Probiotic 90 Billion: 59590 → 250927, organism added to the label
- Renew Life Ultimate Flora RTS Women's Probiotic 15 Billion: 243466 → 275727, organism added to the label
- Renew Life Ultimate Flora RTS Women's Probiotic 15 Billion: 243508 → 275727, organism added to the label
- Renew Life Ultimate Flora RTS Women's Probiotic 15 Billion: 247453 → 275727, organism added to the label
- Renew Life Ultimate Flora RTS Women's Probiotic 15 Billion: 247455 → 275727, organism added to the label
- Renew Life Ultimate Flora RTS Women's Probiotic 15 Billion: 250928 → 275727, organism added to the label
Containing labels21
Evidence amount1.00
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
25 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2021 · Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel-Group, Randomized, Controlled Study.
- 2021 · Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial.
- 2020 · A Randomized Controlled Open Label Crossover Trial to Study Vaginal Colonization of Orally Administered Lactobacillus Reuteri RC-14 and Rhamnosus GR-1 in Pregnant Women at High Risk for Preterm Labor.
- 2020 · Effect of Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the Vaginal Microbiota, Cytokines and Chemokines in Pregnant Women.
- 2020 · Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial.
- 2020 · Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.
- 2019 · Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.
- 2019 · The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial.
- 2019 · Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial.
- 2018 · Pilot assessment of probiotics for pregnant women in Rwanda.
ClinicalTrials.gov
14 interventional studies. ClinicalTrials.gov query
This species has 22 tracked designations; this one appears on 21 labels (median 4).
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 21 of 21 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Metagenics | UltraFlora Women's | 216583 | 84.03 | true | not printed for this organism | through expiry | 1 |
| NHC Natural Healthy Concepts | Probiotic For Women | 294108 | 84.03 | true | not printed for this organism | through expiry | 1 |
| Renew Life | Women's Wellness Vaginal & Urinary Complete | 306966 | 84.03 | true | not printed for this organism | through expiry | 1 |
| TruBiotics | Women's | 316473 | 84.03 | true | not printed for this organism | through expiry | 1 |
| RepHresh | Pro-B Probiotic | 210254 | 77.28 | true | not printed for this organism | at manufacture | 3 |
| Jarrow Formulas | Fem Dophilus | 307586 | 77.28 | true | not printed for this organism | at manufacture | 1 |
| Jarrow Formulas | Fem Dophilus 5 Billion CFU | 307587 | 77.28 | true | not printed for this organism | at manufacture | 1 |
| Jarrow Formulas | Fem Dophilus 1 Billion CFU | 307588 | 77.28 | true | not printed for this organism | at manufacture | 2 |
| Jarrow Formulas | Fem Dophilus 1 Billion CFU | 307589 | 77.28 | true | not printed for this organism | at manufacture | 2 |
| 1MD Nutrition | BiomeMD for Women | 309803 | 73.70 | true | not printed for this organism | through expiry | 1 |
| Renew Life | Ultimate Flora Women's Care Go-Pack Probiotic 15 Billion | 275727 | 70.28 | true | not printed for this organism | through expiry | 9 |
| Renew Life | Ultimate Flora Women's Care Go-Pack Probiotic 15 Billion | 277228 | 70.28 | true | not printed for this organism | through expiry | 9 |
| Renew Life | Probiotics Women's Care 25 Billion CFU | 306960 | 70.28 | true | not printed for this organism | through expiry | 2 |
| Renew Life | Probiotics Women's Care Vaginal 50 Billion CFU | 306961 | 70.28 | true | not printed for this organism | through expiry | 4 |
| Renew Life | Ultimate Flora Women's Vaginal Probiotic 50 Billion | 306962 | 70.28 | true | not printed for this organism | through expiry | 4 |
| Renew Life | Ultimate Flora Health & Wellness Women's Care Probiotic 25 Billion | 250891 | 65.69 | true | not printed for this organism | through expiry | 2 |
| Renew Life | Ultimate Flora Women's Care Probiotic 90 Billion | 250927 | 65.69 | true | not printed for this organism | through expiry | 5 |
| Renew Life | Ultimate Flora Women's Care Probiotic 90 Billion | 275729 | 65.69 | true | not printed for this organism | through expiry | 5 |
| Thorne | Women's Daily Probiotic | 328844 | 41.21 | true | not printed for this organism | not stated | 1 |
| RepHresh | Pro-B | 12221 | Not available in this release. | true | undefined: light snapshot | not stated | 3 |
| Rephresh | Pro-B | 246331 | Not available in this release. | true | undefined: light snapshot | not stated | 3 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Limosilactobacillus reuteri RC-14. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/limosilactobacillus-reuteri-rc-14/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Limosilactobacillus reuteri RC-14 appears on 21 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 9 brands; tied with 3 designations by distinct label count.
21 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 21 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Limosilactobacillus reuteri RC-14 (0.0%); 2 light records have quantities unavailable.
0 / 21 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f73243725 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 25 records (retracted records excluded; 0 retracted records match the query separately).
25 / 25 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f73243714 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
14 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371 of 14 SKUs containing Limosilactobacillus reuteri RC-14 have a numeric price observation (7.1%) in the release accompanying the NIH DSLD snapshot Sep 2026.
1 / 14 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437